Isocitric acid
|
Basic information |
| Metabolite name | Isocitric acid |
 | HMDB0000193 |
 |
C00311 |
 |
1198 |
| Synonyms | Isocitrate; |
| No. of studies | 9 |
|
Basic information |
| Metabolite name | Isocitric acid |
| HMDB0000193 |
|
C00311 |
|
1198 |
| Synonyms | Isocitrate; |
| No. of studies | 9 |
|
Relationship between Isocitric acid and depression (count: 9) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M019 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Down |
| Study M022 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Down |
| Study M086 | Type5 | paroxetine-treated responder group vs. non-responder group | Hippocampus | DBA/2J mouse | Up |
| Study M115 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M577 | Type1 | female depression group vs. female control group, aged 30-39 | Urine | Human | Unknown |
| Study M577 | Type1 | female depression group vs. female control group, aged 40-49 | Urine | Human | Unknown |
| Study M577 | Type1 | male depression group vs. male control group, aged 30-39 | Urine | Human | Unknown |
| Study M664 | Type1 | CSDS group vs. control group | Prefrontal cortex | C57BL/6 J mouse | Down |
| Study M715 | Type1 | MDD group vs. control group | Faece | Human | Up |
| Study M762 | Type2 | corticosterone + metformin group vs. corticosterone group | Liver | Wistar rat | Down |
| Study M885 | Type1 | CMS-vulnerable group vs. control group | Ventral hippocampus | Wistar rat | Down |